Logo image of ALBPK.PA

BROADPEAK (ALBPK.PA) Stock Fundamental Analysis

EPA:ALBPK - Euronext Paris - Matif - FR001400AJZ7 - Common Stock - Currency: EUR

1.26  -0.03 (-2.33%)

Fundamental Rating

2

Overall ALBPK gets a fundamental rating of 2 out of 10. We evaluated ALBPK against 26 industry peers in the Communications Equipment industry. ALBPK may be in some trouble as it scores bad on both profitability and health. ALBPK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALBPK had negative earnings in the past year.
In the past year ALBPK had a positive cash flow from operations.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.81%, ALBPK is doing worse than 61.54% of the companies in the same industry.
ALBPK has a Return On Equity (-25.58%) which is in line with its industry peers.
Industry RankSector Rank
ROA -9.81%
ROE -25.58%
ROIC N/A
ROA(3y)1.62%
ROA(5y)N/A
ROE(3y)12.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 40

1.3 Margins

ALBPK has a Gross Margin of 96.76%. This is amongst the best in the industry. ALBPK outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALBPK has grown nicely.
ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.48%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALBPK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ALBPK is higher compared to a year ago.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 0.57, we must say that ALBPK is in the distress zone and has some risk of bankruptcy.
ALBPK has a Altman-Z score of 0.57. This is in the lower half of the industry: ALBPK underperforms 69.23% of its industry peers.
ALBPK has a Debt/Equity ratio of 0.50. This is a neutral value indicating ALBPK is somewhat dependend on debt financing.
The Debt to Equity ratio of ALBPK (0.50) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACCN/A
WACC6.43%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALBPK has a Current Ratio of 1.31. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.31, ALBPK is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
A Quick Ratio of 1.30 indicates that ALBPK should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.30, ALBPK perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.3
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALBPK have decreased strongly by -479.62% in the last year.
The Revenue for ALBPK has decreased by -13.13% in the past year. This is quite bad
ALBPK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.67% yearly.
EPS 1Y (TTM)-479.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.6%
Revenue 1Y (TTM)-13.13%
Revenue growth 3Y17.67%
Revenue growth 5YN/A
Sales Q2Q%-4.96%

3.2 Future

Based on estimates for the next years, ALBPK will show a very strong growth in Earnings Per Share. The EPS will grow by 30.36% on average per year.
The Revenue is expected to grow by 6.38% on average over the next years.
EPS Next Y52.69%
EPS Next 2Y41.04%
EPS Next 3Y30.36%
EPS Next 5YN/A
Revenue Next Year2.44%
Revenue Next 2Y5.19%
Revenue Next 3Y6.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBPK. In the last year negative earnings were reported.
Also next year ALBPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALBPK's earnings are expected to grow with 30.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.04%
EPS Next 3Y30.36%

More info and screens

0

5. Dividend

5.1 Amount

ALBPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROADPEAK

EPA:ALBPK (3/7/2025, 7:00:00 PM)

1.26

-0.03 (-2.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.4%
Inst Owner ChangeN/A
Ins Owners49.06%
Ins Owner ChangeN/A
Market Cap15.80M
Analysts86
Price Target2.7 (114.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.64%
PT rev (3m)-3.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.76%
EPS NY rev (3m)-12.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.11%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF 6.91
P/B 0.81
P/tB 5.11
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)0.18
OCFY14.47%
SpS3.04
BVpS1.56
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.81%
ROE -25.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.76%
FCFM N/A
ROA(3y)1.62%
ROA(5y)N/A
ROE(3y)12.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.48%
GM growth 5YN/A
F-Score2
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 256.44%
Cap/Sales 31.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.3
Altman-Z 0.57
F-Score2
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)418.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)19.39%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-479.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.6%
EPS Next Y52.69%
EPS Next 2Y41.04%
EPS Next 3Y30.36%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.13%
Revenue growth 3Y17.67%
Revenue growth 5YN/A
Sales Q2Q%-4.96%
Revenue Next Year2.44%
Revenue Next 2Y5.19%
Revenue Next 3Y6.38%
Revenue Next 5YN/A
EBIT growth 1Y-355.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.17%
EBIT Next 3Y42.83%
EBIT Next 5YN/A
FCF growth 1Y-193.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y851.97%
OCF growth 3YN/A
OCF growth 5YN/A